Drug-induced thrombocytopenia: a case report

被引：0

作者：

Chavez, K. Rodriguez ^{[1
]}

Brandl, E. ^{[1
]}

Wilfi, A. ^{[1
]}

Tillinger, W. ^{[1
]}

机构：

[1] Hartmannspital Wien, Vienna, Austria

来源：

TUMORBOARD | 2016年 / 01期

关键词：

Thrombocytopenia; drug-induced; Acetazolamide; Carbonic Anhydrase Inhibitor; Sulfonamide; antibodies; antigen; immunereaction; hemorraghes; glucocorticoid; plasmapheresis;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Drug-induced thrombocytopenia should be considered in any patient who presents with acute thrombocytopenia of unknown cause. Suspicious medication should be discontinued immediatly. To react adequatly diagnosis and treatment should not be delayed by laboratory testing but rather defined by clinical criteria.

引用

页码：9 / 11

页数：3

共 50 条

[21] Drug-induced immune thrombocytopenia
van den Bemt, PMLA
Meyboom, RHB
Egberts, ACG
DRUG SAFETY, 2004, 27 (15) : 1243 - 1252
[22] DRUG-INDUCED IMMUNE THROMBOCYTOPENIA
KIEFEL, V
MUELLERECKHARDT, C
BLUT, 1988, 57 (04): : 215 - 215
[23] DRUG-INDUCED IMMUNOLOGICAL THROMBOCYTOPENIA
ALPERIN, JB
AMERICAN JOURNAL OF MEDICAL TECHNOLOGY, 1979, 45 (05): : 436 - 436
[24] Drug-induced immune thrombocytopenia
Matzdorff, Axel C.
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (18): : 1870 - 1870
[25] DRUG-INDUCED IMMUNE THROMBOCYTOPENIA
MOSS, RA
AMERICAN JOURNAL OF HEMATOLOGY, 1980, 9 (04) : 439 - 446
[26] Drug-Induced Immune Thrombocytopenia
Patricia M. L. A. van den Bemt
Ronald H. B. Meyboom
Antoine C. G. Egberts
Drug Safety, 2004, 27 : 1243 - 1252
[27] Drug-induced Immune Thrombocytopenia
Chong, Beng H.
Choi, Philip Young-Ill
Khachigian, Levon
Perdomo, Jose
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (03) : 521 - +
[28] Diagnosis of drug-induced thrombocytopenia
Chong, Beng H.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 10 - 11
[29] Dealing with drug-induced thrombocytopenia
Kelton, JG
Cassileth, PA
HOSPITAL PRACTICE, 1998, 33 (05): : 37 - +
[30] NEUROLEPTIC DRUG-INDUCED THROMBOCYTOPENIA
HOLT, RJ
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (06): : 437 - 437

← 1 2 3 4 5 →